Join
Live feed
·
PRReleasevia Quantisnow
Precision BioSciences Inc. logo

Precision BioSciences Outlines Clinical Development Strategy for In Vivo Gene Editing Pipeline

ByQuantisnow·Wall Street's wire, on your screen.
DTIL· Precision BioSciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DTIL (Precision BioSciences Inc.) and more on Quantisnow.